Clinical Trial Results

Showing: All studies [change]
Condition: Diabetes Location: Michigan 17 trials found
New Search
Filter
Trial Phase
What's the difference?
Study Type
What's the difference?
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
PHASE2INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
PHASE2INTERVENTIONAL Lancaster, California +4 more
RECRUITING
ECHO Diabetes FQHC
N/AOBSERVATIONAL Miami, Florida +1 more
RECRUITING
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
NAINTERVENTIONAL Los Angeles, California +4 more
RECRUITING
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
NAINTERVENTIONAL Los Angeles, California +4 more
RECRUITING
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
PHASE3INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
PHASE3INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
PHASE3INTERVENTIONAL Cullman, Alabama +4 more
RECRUITING
Empagliflozin Treatment in Kidney Transplant Recipients
PHASE4INTERVENTIONAL Hines, Illinois +4 more
RECRUITING
RCT Glargine vs NPH for Treatment of DM in Pregnancy
PHASE3INTERVENTIONAL Maywood, Illinois
RECRUITING
Filter Trials
Trial Phase
Study Type